tiprankstipranks
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
Hong Kong Market
1513
Livzon Pharmaceutical Group
RESEARCH TOOLSreports

Livzon Pharmaceutical Group (1513) Income Statement

Compare
1 Followers

Livzon Pharmaceutical Group Income Statement

Last quarter (Q4 2025), Livzon Pharmaceutical Group's total revenue was ¥2.86B, an increase of 4.79% from the same quarter last year. In Q4, Livzon Pharmaceutical Group's net income was ¥265.18M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 11.60B¥ 11.81B¥ 12.43B¥ 12.63B¥ 12.06B
Gross Profit
¥ 7.43B¥ 7.73B¥ 7.66B¥ 8.17B¥ 7.81B
Operating Expenses
¥ 4.88B¥ 4.89B¥ 5.24B¥ 5.93B¥ 5.62B
Depreciation and Amortization
¥ 539.01M¥ 575.14M¥ 840.32M¥ 652.32M¥ 445.27M
EBITDA
¥ 3.10B¥ 3.47B¥ 3.33B¥ 3.08B¥ 2.77B
Operating Income
¥ 2.56B¥ 2.84B¥ 2.42B¥ 2.35B¥ 2.27B
Other Income/Expenses
¥ 231.74M¥ -38.25M¥ -32.44M¥ -20.01M¥ -21.30M
Pretax Income
¥ 2.79B¥ 2.81B¥ 2.38B¥ 2.33B¥ 2.25B
Net Income
¥ 1.97B¥ 2.06B¥ 1.95B¥ 1.91B¥ 1.78B
Per Share Metrics
Basic EPS
¥ 2.21¥ 2.24¥ 2.10¥ 2.04¥ 1.90
Diluted EPS
¥ 2.21¥ 2.24¥ 2.10¥ 2.04¥ 1.90
Weighted Average Shares Outstanding
 893.10M 920.13M 930.31M 933.86M 934.46M
Weighted Average Shares Outstanding (Diluted)
 893.10M 920.13M 930.61M 935.98M 934.57M
Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History